BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 23407718)

  • 1. APOE ε4 increases risk for dementia in pure synucleinopathies.
    Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Trojanowski JQ; Weintraub D; Chen-Plotkin AS; Irwin DJ; Rick J; Schellenberg GD; Watson GS; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Quinn JF; Chung KA; Yearout D; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP
    JAMA Neurol; 2013 Feb; 70(2):223-8. PubMed ID: 23407718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
    Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Trojanowski JQ; Schellenberg GD; Yearout D; Huston H; Fritts-Penniman A; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP
    Neurology; 2012 Nov; 79(19):1944-50. PubMed ID: 23035075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
    Gan J; Chen Z; Liu S; Shi Z; Liu Y; Wang XD; Liu C; Ji Y
    BMC Neurol; 2022 Sep; 22(1):355. PubMed ID: 36123648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
    Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
    Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
    Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
    Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of APOE in atypical parkinsonism syndromes.
    Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
    Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
    Lane R; He Y; Morris C; Leverenz JB; Emre M; Ballard C
    Mov Disord; 2009 Feb; 24(3):392-400. PubMed ID: 19006190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review.
    Liampas I; Kyriakoulopoulou P; Siokas V; Tsiamaki E; Stamati P; Kefalopoulou Z; Chroni E; Dardiotis E
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.
    Kobayashi S; Tateno M; Park TW; Utsumi K; Sohma H; Ito YM; Kokai Y; Saito T
    PLoS One; 2011 Apr; 6(4):e18569. PubMed ID: 21552550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The
    Saeed U; Desmarais P; Masellis M
    Expert Rev Neurother; 2021 Aug; 21(8):851-870. PubMed ID: 34311631
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropathologic substrates of Parkinson disease dementia.
    Irwin DJ; White MT; Toledo JB; Xie SX; Robinson JL; Van Deerlin V; Lee VM; Leverenz JB; Montine TJ; Duda JE; Hurtig HI; Trojanowski JQ
    Ann Neurol; 2012 Oct; 72(4):587-98. PubMed ID: 23037886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
    Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP
    Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
    van der Lee SJ; van Steenoven I; van de Beek M; Tesi N; Jansen IE; van Schoor NM; Reinders MJT; Huisman M; Scheltens P; Teunissen CE; Holstege H; van der Flier WM; Lemstra AW
    J Alzheimers Dis; 2021; 83(1):269-279. PubMed ID: 34308904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
    Kaivola K; Shah Z; Chia R; ; Scholz SW
    Brain; 2022 Jun; 145(5):1757-1762. PubMed ID: 35381062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE DNA methylation is altered in Lewy body dementia.
    Tulloch J; Leong L; Chen S; Keene CD; Millard SP; Shutes-David A; Lopez OL; Kofler J; Kaye JA; Woltjer R; Nelson PT; Neltner JH; Jicha GA; Galasko D; Masliah E; Leverenz JB; Yu CE; Tsuang D
    Alzheimers Dement; 2018 Jul; 14(7):889-894. PubMed ID: 29544979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.